<SEC-DOCUMENT>0001437749-24-014120.txt : 20240501
<SEC-HEADER>0001437749-24-014120.hdr.sgml : 20240501
<ACCEPTANCE-DATETIME>20240501132226
ACCESSION NUMBER:		0001437749-24-014120
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240425
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240501
DATE AS OF CHANGE:		20240501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stock Yards Bancorp, Inc.
		CENTRAL INDEX KEY:			0000835324
		STANDARD INDUSTRIAL CLASSIFICATION:	STATE COMMERCIAL BANKS [6022]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				611137529
		STATE OF INCORPORATION:			KY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13661
		FILM NUMBER:		24901971

	BUSINESS ADDRESS:	
		STREET 1:		1040 E MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40206
		BUSINESS PHONE:		5025822571

	MAIL ADDRESS:	
		STREET 1:		1040 EAST MAIN STREET
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40206

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	S Y BANCORP INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sybt20240501_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:sybt="http://www.sybt.com/20240425"><head>
	<title>sybt20240501_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 5/1/2024 4:57:23 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20248K" name="dei:AmendmentFlag" id="ixv-607">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20248K" name="dei:EntityCentralIndexKey" id="ixv-608">0000835324</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="sybt-20240425.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="d20248K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000835324</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-04-25</xbrli:startDate>
<xbrli:endDate>2024-04-25</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;"><b>UNITED STATES</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">Washington, D.C. 20549</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;"><b>FORM <ix:nonNumeric contextRef="d20248K" name="dei:DocumentType" id="ixv-16"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">CURRENT REPORT</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;"><b>PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="d20248K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-618">April 25, 2024</ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; margin: 0pt; text-align: center;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityRegistrantName" id="ixv-27"><b>STOCK YARDS BANCORP, INC.</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">(Exact name of registrant as specified in its charter)</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-37"><span style="text-decoration: underline;">Kentucky</span></ix:nonNumeric></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(State or other jurisdiction of</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">incorporation or organization)</div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityFileNumber" id="ixv-43"><span style="text-decoration: underline;">001-13661</span></ix:nonNumeric></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align: top; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityTaxIdentificationNumber" id="ixv-48"><span style="text-decoration: underline;">61-1137529</span></ix:nonNumeric></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">(I.R.S. Employer</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;"><span style="text-decoration: underline;"><ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressAddressLine1" id="ixv-55"><span style="text-decoration: underline;">1040 East Main Street</span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressCityOrTown" id="ixv-57"><span style="text-decoration: underline;">Louisville</span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-59"><span style="text-decoration: underline;">Kentucky</span></ix:nonNumeric>, <ix:nonNumeric contextRef="d20248K" name="dei:EntityAddressPostalZipCode" id="ixv-61"><span style="text-decoration: underline;">40206</span></ix:nonNumeric></span></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">(Address of principal executive offices)</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;"><span style="text-decoration: underline;">(<ix:nonNumeric contextRef="d20248K" name="dei:CityAreaCode" id="ixv-67"><span style="text-decoration: underline;">502</span></ix:nonNumeric>) <ix:nonNumeric contextRef="d20248K" name="dei:LocalPhoneNumber" id="ixv-69"><span style="text-decoration: underline;">582-2571</span></ix:nonNumeric></span></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;">(Registrant's telephone number, including area code)</div>

<div style="margin: 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="ixv-619">&#9744;</ix:nonNumeric></div>
			</td>
			<td colspan="2" style="vertical-align:top;width:50.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:2.1%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;width:50.2%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="ixv-620">&#9744;</ix:nonNumeric></div>
			</td>
			<td colspan="2" style="vertical-align:top;width:50.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:2.1%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;width:50.2%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="ixv-621">&#9744;</ix:nonNumeric></div>
			</td>
			<td colspan="2" style="vertical-align:top;width:50.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:2.1%;">&#160;</td>
			<td colspan="2" style="vertical-align:top;width:50.2%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="ixv-622">&#9744;</ix:nonNumeric></div>
			</td>
			<td colspan="2" style="vertical-align:top;width:50.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 35%; padding-left: 9pt; border-width: 1px; border-style: solid; border-color: black;">Title of each class</td>
			<td style="vertical-align: bottom; width: 20%; border-top: 1px solid black; border-bottom: 1px solid black; border-right: 1px solid black;">
			<div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt 0pt 0pt 9pt;">Trading</div>

			<div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt 0pt 0pt 9pt;">Symbol(s)</div>
			</td>
			<td style="vertical-align: bottom; width: 45%; padding-left: 9pt; border-top: 1px solid black; border-bottom: 1px solid black; border-right: 1px solid black;">Name of each exchange on which registered</td>
		</tr>
		<tr>
			<td style="vertical-align: bottom; width: 35%; padding-left: 9pt; border-bottom: 1px solid black; border-left: 1px solid black; border-right: 1px solid black;"><ix:nonNumeric contextRef="d20248K" name="dei:Security12bTitle" id="ixv-623">Common stock</ix:nonNumeric>, no par value</td>
			<td style="vertical-align: bottom; width: 20%; padding-left: 9pt; border-bottom: 1px solid black; border-right: 1px solid black;"><ix:nonNumeric contextRef="d20248K" name="dei:TradingSymbol" id="ixv-624">SYBT</ix:nonNumeric></td>
			<td style="vertical-align: bottom; width: 45%; padding-left: 9pt; border-bottom: 1px solid black; border-right: 1px solid black;">The <ix:nonNumeric contextRef="d20248K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-625">NASDAQ</ix:nonNumeric> Stock Market, LLC</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;">Emerging growth company&#160;<ix:nonNumeric contextRef="d20248K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="ixv-626">&#9744;</ix:nonNumeric></div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 5.02</b>&#160;&#160;&#160;<b>&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">As discussed in Item 5.07 below, at the 2024 annual meeting of shareholders held on April 25, 2024, shareholders of Stock Yards Bancorp, Inc. (the &#8220;Company&#8221;) approved the Amended and Restated Stock Yards Bancorp, Inc. Omnibus Equity Compensation Plan (the &#8220;Amended and Restated Plan&#8221;).&#160;&#160;The Amended and Restated Plan increased&#160;the number of shares of the Company&#8217;s Common Stock reserved and available for issuance under the Amended and Restated Plan by 1,000,000 shares. The Amended and Restated Plan also modified various terms and features of the plan to clarify existing provisions, better align the plan with current market practices and add certain features intended to benefit shareholders as follows:</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Requires a minimum vesting period of one year for at least 95% of the total shares authorized to be issued under the Amended and Restated Plan;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Prohibits the payment or vesting of dividends or dividend equivalents on unvested awards;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Limits the value of all awards to individual non-employee directors in any calendar year to $100,000;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Expressly allows broker-assisted cashless exercises and &#8220;net exercises&#8221; for stock options;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Specifies that stock-based awards will be paid to plan participants whose employment ends within 24 months after a change of control event at the greater of their target values or the actual level of achievement, instead of simply target values; and</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Requires that all awards be subject to any compensation recovery (claw-back), forfeiture or recoupment policy adopted by the Board of Directors from time to time, including the Company&#8217;s Compensation Recoupment Policy recently adopted pursuant to Section 954 of the Dodd-Frank Act.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">A summary of the material terms of the Amended and Restated Plan appears on pages 29 to 33 of the Company&#8217;s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on March 14, 2024 (the &#8220;Proxy Statement&#8221;), and is incorporated herein by reference. That summary and the foregoing description do not purport to be complete and are qualified in their entirety by reference to the actual text of the Amended and Restated Plan, a copy of which is filed as Exhibit 10.1 hereto and is incorporated into this report by reference.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 5.07</b>&#160;<b>&#160;</b>&#160;&#160;<b>Submission of Matters to a Vote of Security Holders.</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">On April 25, 2024, the Company held its 2024 annual meeting of shareholders (the &#8220;Annual Meeting&#8221;). Shareholders were requested to consider and vote upon four proposals, each of which is more fully described in the Proxy Statement. As of the record date for the Annual Meeting, there were 29,366,737 shares of Common Stock outstanding and entitled to one vote on each matter presented for vote at the Annual Meeting. At the Annual Meeting, 24,678,810 or 84.03% of the outstanding common shares entitled to vote were represented in person or by proxy. Those shares were voted as set forth below.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">1.</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The following individuals were nominated in 2024 to serve as directors of the Company until the next annual meeting of shareholders in 2025. All nominees were elected by the following tabulation of votes.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 90%; margin-left: 27pt; margin-right: auto;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Votes For</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Votes</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Against</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Abstain</div>
			</td>
			<td style="vertical-align: middle; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Broker Non-</div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">Votes</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Shannon B. Arvin</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,014,338</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;675,815</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,740</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Paul J. Bickel III</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,463,504</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;198,241</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;48,148</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Allison J. Donovan</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;18,939,149</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;726,063</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;44,681</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">David P. Heintzman</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,203,042</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;411,570</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;95,281</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Carl G. Herde</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;18,954,148</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;711,275</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;44,460</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">James A. Hillebrand</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,277,160</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;409,875</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;22,858</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard A. Lechleiter</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,163,486</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;502,697</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;43,710</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Philip S. Poindexter</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,244,145</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;418,276</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;47,472</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Stephen M. Priebe</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;18,285,878</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;1,343,808</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;80,207</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Edwin S. Saunier</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,483,503</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;204,102</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;22,288</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">John L. Schutte</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;19,511,388</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;154,982</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;43,523</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Laura L. Wells</div>
			</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;16,788,107</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;2,837,574</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;84,212</div>
			</td>
			<td style="vertical-align: bottom; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">&#160;</td>
			<td style="vertical-align: bottom; width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#160;4,968,917</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">2.</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Ratification of the selection of FORVIS, LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024 was approved by the following tabulation of votes.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-size: 10pt; text-align: justify; color: rgb(51, 51, 51);">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 20%; margin-left: 27pt; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">23,086,093</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Against</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">76,713</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Abstain</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">1,516,004</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">3.</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The proposal to approve a non-binding resolution to approve the compensation of the Company&#8217;s named executive officers was approved by the following tabulation of votes.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 20%; margin-left: 27pt; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">19,168,714</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Against</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">394,578</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Abstain</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">146,601</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Broker Non-Votes</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">4,968,917</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">4.</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The proposal to approve the amendment and restatement of the 2015 Omnibus Equity Compensation Plan was approved by the following tabulation of votes.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 20%; margin-left: 27pt; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">For</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">19,038,003</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Against</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">461,612</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Abstain</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">210,278</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Broker Non-Votes</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">4,968,917</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 9.01&#160; &#160; &#160;Financial Statements and Exhibits.</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(d)&#160;&#160;<i>Exhibits</i></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">10.1</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><a href="ex_665175.htm" style="-sec-extract:exhibit;">Stock Yards Bancorp, Inc. Amended and Restated Omnibus Equity Compensation Plan</a></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">104</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt; text-align: center;"><b>SIGNATURES</b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin: 0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tbody><tr>
			<td style="width: 50%; width: 50%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Date:&#160;&#160;&#160;May 1, 2024</div>
			</td>
			<td colspan="2" style="width: 38%; width: 3%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">STOCK YARDS BANCORP, INC.</div>
			</td>
			<td style="width: 12%; width: 17%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 50%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 3%; width: 3%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td align="left" style="nowrap: nowrap; width: 35%; width: 30%;" valign="bottom">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 12%; width: 17%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
		</tr>
		<tr>
			<td align="left" style="width: 50%; text-align: left; width: 50%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 3%; text-align: left; width: 3%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </span></div>
			</td>
			<td align="left" style="nowrap: nowrap; width: 35%; border-bottom: 1px solid rgb(0, 0, 0); width: 30%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"><span style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&#160;</span>T. Clay Stinnett</div>
			</td>
			<td style="width: 12%; width: 17%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 50%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 3%; width: 3%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 35%; width: 30%;" valign="top">
			<div style="margin: 0px 0pt 0px 9pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">T. Clay Stinnett, Executive Vice</div>
			</td>
			<td style="width: 12%; width: 17%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 50%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 3%; width: 3%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
			<td style="width: 35%; width: 30%;" valign="top">
			<div style="margin: 0px 0pt 0px 9pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">President, Treasurer and Chief</div>
			</td>
			<td style="width: 12%; width: 17%;" valign="top">
			<div style="margin: 0px 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;"></div>
			</td>
		</tr>
		<tr>
			<td style="width: 50%; width: 50%;" valign="top">&#160;</td>
			<td style="width: 3%; width: 3%;" valign="top">&#160;</td>
			<td style="width: 35%; padding-left: 9pt; width: 30%;" valign="top">Financial Officer</td>
			<td style="width: 12%; width: 17%;" valign="top">&#160;</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_665175.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_665175.htm</title>

	<!-- Generated by ThunderDome Portal - 5/1/2024 4:57:55 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><b>STOCK YARDS BANCORP, INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AMENDED AND RESTATED OMNIBUS EQUITY COMPENSATION PLAN</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 1</b>&#8212;<b> INTRODUCTION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>1.1&nbsp;</b>&nbsp; &nbsp;&nbsp;<b>Effectiveness and Impact on Prior Plan. </b>Effective as of the Effective Date (as defined below), the Stock Yards Bancorp Amended and Restated Omnibus Equity Compensation Plan (the "<b><i>Plan</i></b>") is hereby established to amend and restate the 2015 Omnibus Equity Compensation Plan (the &#8220;2015 Plan&#8221;), which was the successor to the S.Y. Bancorp 2005 Stock Incentive Plan, as amended (the "<b><i>2005 Plan</i></b>"). No additional grants shall be made thereafter under the 2005 or the 2015 Plans. Outstanding grants under the 2005 and 2015 Plans shall continue in effect according to their terms as in effect before the amendment and restatement (subject to such amendments as the Committee (as defined below) determines, consistent with the 2005 or 2015 Plans, as applicable), and the shares with respect to outstanding grants under the 2005 or 2015 Plans shall be issued or transferred under this Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>1.2&nbsp;</b>&nbsp; &nbsp; &nbsp;<b>Purpose</b>. The purpose of the Plan is to provide (i) designated employees of Stock Yards Bancorp, Inc. (the "<b><i>Company</i></b>") and its subsidiaries and (ii) non-employee members of the Board with the opportunity to receive grants of stock options, stock units, stock awards, stock appreciation rights and other stock-based awards. The Company believes that the Plan will encourage the Participants to contribute materially to the growth of the Company, thereby benefiting the Company's shareholders, and will align the economic interests of the Participants with those of the shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 2</b>&#8212;<b>DEFINITIONS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">As used in the Plan, the following terms will have the respective meanings set forth below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>2.1&nbsp; &nbsp; &nbsp;&nbsp;</b><i>"</i><b><i>Board</i></b><i>" </i>means the Company's Board of Directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>2.2</b>&nbsp;&nbsp; &nbsp; &nbsp;A "<b><i>Change of Control</i></b>" shall be deemed to have taken place for purposes of the Plan if</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt;">(a)&nbsp; &nbsp; &nbsp;any Person (as defined in this Section 2.2) is or becomes the Beneficial Owner (as defined in this Section 2.2) of securities of the Company representing 20% or more of the combined voting power of the Company's then outstanding securities (unless (A) such Person is the Beneficial Owner of 20% or more of such securities as of the Effective Date or (B) the event causing the 20% threshold to be crossed is an acquisition of securities directly from the Company);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt;">(b)&nbsp; &nbsp; &nbsp; during any period of two consecutive years beginning after the Effective Date, individuals who at the beginning of such period constitute the Board and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in clause (a), (c) or (d) of this Change in Control definition) whose election or nomination for election was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved cease for any reason to constitute a majority of the Board;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt;">(c)&nbsp; &nbsp; &nbsp; the consummation of a merger or consolidation of the Company with any other corporation (other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the entity surviving such merger or consolidation), in combination with voting securities of the Company or such surviving entity held by a trustee or other fiduciary pursuant to any employee benefit plan of the Company or such surviving entity or of any Subsidiary of the Company or such surviving entity, at least 80% of the combined voting power of the securities of the Company or such surviving entity outstanding immediately after such merger or consolidation);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt;">(d)&nbsp; &nbsp; &nbsp; the shareholders of the Company approve a plan of complete liquidation or dissolution of the Company; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt;">(e)&nbsp; &nbsp; &nbsp; the consummation of an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For purposes of the definition of Change in Control, "<b><i>Person</i></b>" shall have the meaning ascribed to such tern) in Section 3(a)(9) of the Exchange Act as supplemented by Section 13(d)(3) of the Exchange Act; provided, however, that Person shall not include (i) the Company, any Subsidiary or any other Person controlled by the Company, (ii) any trustee or other fiduciary holding securities under any employee benefit plan of the Company or of any Subsidiary, or (iii) a corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of securities of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For purposes of the definition of Change of Control, a Person shall be deemed the "<b><i>Beneficial Owner</i></b>" of any securities which such Person, directly or indirectly, has the right to vote or dispose of or has "beneficial ownership" (within the meaning of Rule 13d-3 under the Exchange Act) of, including pursuant to any agreement, arrangement or understanding (whether or not in writing) ; provided, however, that: (i) a Person shall not be deemed the Beneficial Owner of any security as a result of an agreement, arrangement or understanding to vote such security (x) arising solely from a revocable proxy or consent given in response to a public proxy or consent solicitation made pursuant to, and in accordance with, the Exchange Act and the applicable rules and regulations thereunder or (y) made in connection with, or to otherwise participate in, a proxy or consent solicitation made, or to be made, pursuant to, and in accordance with, the applicable provisions of the Exchange Act and the applicable rules and regulations thereunder; in either case described in clause (x) or clause (y) above, whether or not such agreement, arrangement or understanding is also then reportable by such Person on Schedule 13D under the Exchange Act (or any comparable or successor report); and (ii) a Person engaged in business as an underwriter of securities shall not be deemed to be the Beneficial Owner of any securities acquired through such Person's participation in good faith in a firm commitment underwriting until the expiration of forty days after the date of such acquisition.</p>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Notwithstanding the foregoing, for any Grants subject to the requirements of section 409A of the Code that will become payable on a Change of Control, the transaction constituting a "Change of Control" must also constitute a "change in control event" for purposes of section 409A(a)(2)(A)(v) of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.3</b>&nbsp; &nbsp; &nbsp;&nbsp;<i>"</i><b><i>Code</i></b><i>" </i>means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.4</b>&nbsp; &nbsp; &nbsp;<i>"</i><b><i>Committee</i></b><i>" </i>means (i) with respect to Grants to Employees, the Compensation Committee of the Board or another committee appointed by the Board to administer the Plan, and (ii) with respect to Grants made to Non-Employee Directors, the Board.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.5</b>&nbsp; &nbsp; &nbsp;&nbsp;<i>"</i><b><i>Company</i></b><i>" </i>means Stock Yards Bancorp, Inc., its subsidiary corporations or other entities and any successor corporation, as determined by the Committee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.6</b>&nbsp; &nbsp; &nbsp;&nbsp;<b><i>"Company Stock</i></b><i>" </i>means the Common Stock of the Company, no par value per share, or any stock or other securities of the Company hereafter issued or issuable in substitution or exchange for the Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.7</b>&nbsp; &nbsp; &nbsp;&nbsp;<i>"</i><b><i>Disability</i></b><i>" </i>or <i>"</i><b><i>Disabled</i></b><i>" </i>means a Participant's becoming disabled within the meaning of Section 22(e)(3) of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.8</b>&nbsp; &nbsp; &nbsp;&nbsp;<b><i>"Dividend Equivalent</i></b><i>" </i>means an amount calculated with respect to a Stock Unit, which is determined by multiplying the number of shares of Company Stock subject to the Stock Unit by the per-share cash dividend, or the per-share fair market value (as determined by the Committee) of any dividend in consideration other than cash, paid by the Company on its Company Stock. If interest is credited on accumulated dividend equivalents, the term "Dividend Equivalent" shall include the accrued interest.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.9</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>"</b><b><i>Effective Date</i></b>" of the Plan means April 25, 2024<b>, </b>provided that the Plan is approved by the shareholders of the Company on that date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.10</b>&nbsp; &nbsp;<i>"</i><b><i>Employee</i></b><i>" </i>means an employee of the Employer (including an officer or director who is also an employee), but excluding any person who is classified by the Employer as a "contractor" or "consultant," no matter how characterized by the Internal Revenue Service, other governmental agency or a court. Any change of characterization of an individual by the Internal Revenue Service or any court or government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the Committee determines otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.11</b>&nbsp; &nbsp;&nbsp;<b><i>"Employer</i></b><i>" </i>means the Company and its subsidiaries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.12&nbsp;</b>&nbsp; &nbsp;<b><i>"Exchange Act</i></b><i>" </i>means the Securities Exchange Act of 1934, as amended.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.13</b>&nbsp; &nbsp;&nbsp;<b><i>"Exercise Price</i></b><i>" </i>means the per share price at which shares of Company Stock may be purchased under an Option, as designated by the Committee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.14</b>&nbsp; &nbsp;&nbsp;<b><i>"Fair Market Value</i></b><i>" </i>of Company Stock means, (i) if the principal trading market for the Company Stock is a national securities exchange, the last reported sale price of Company Stock during regular trading hours on the relevant date or (if there were no trades on that date) the last reported sale price of Company Stock during regular trading hours on the latest preceding date upon which a sale was reported, (ii) if the Company Stock is not principally traded on such exchange, the mean between the last reported "bid" and "asked" prices of Company Stock on the relevant date, as reported on the OTC Bulletin Board, or (iii) if the Company Stock is not publicly traded or, if publicly traded, is not so reported, the Fair Market Value per share shall be as determined by the Committee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.15&nbsp;</b>&nbsp; &nbsp;<b><i>"Grant</i></b><i>" </i>means an Option, Stock Unit, Stock Award, SAR or Other Stock-Based Award granted under the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.16</b>&nbsp; &nbsp;&nbsp;<b><i>"Grant Agreement</i></b><i>" </i>means the written instrument that sets forth the terms and conditions of a Grant, including all amendments thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.17&nbsp;</b>&nbsp; &nbsp;<b><i>"Incentive Stock Option"</i></b><i> </i>means an Option that is intended to meet the requirements of an incentive stock option under section 422 of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.18&nbsp;</b>&nbsp; &nbsp;<b><i>"Non-Employee Director</i></b><i>" </i>means a member of the Board who is not an Employee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.19&nbsp;&nbsp;</b>&nbsp;&nbsp;<b><i>"Nonqualified Stock Option</i></b><i>" </i>means an Option that is not intended to be taxed as an incentive stock option under section 422 of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.20&nbsp;</b>&nbsp;&nbsp;&nbsp;<b>"</b><b><i>1933 Act</i></b>" means the Securities Act of 1933, as amended.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.21&nbsp;</b>&nbsp;&nbsp;&nbsp;<b><i>"Option</i></b><i>" </i>means an option to purchase shares of Company Stock, as described in Section 7.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.22</b>&nbsp; &nbsp;&nbsp;<b><i>"Other Stock-Based Award</i></b><i>" </i>means any Grant based on, measured by or payable in Company Stock (other than an Option, Stock Unit, Stock Award or SAR), as described in Section&nbsp;11.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.23</b>&nbsp; &nbsp;&nbsp;<b><i>"Participant</i></b><i>" </i>means an Employee or a Non-Employee Director designated by the Committee to participate in the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.24</b>&nbsp; &nbsp;&nbsp;<b><i>"Plan</i></b><i>" </i>means this Stock Yards Bancorp, Inc. Amended and Restated Omnibus Equity Compensation Plan, as may be amended from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.25</b>&nbsp; &nbsp;&nbsp;<b><i>"SAR</i></b><i>" </i>means a stock appreciation right as described in Section 10.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.26</b>&nbsp; &nbsp;&nbsp;<b><i>"Stock Award</i></b><i>" </i>means an award of Company Stock as described in Section 9.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>2.27</b>&nbsp; &nbsp;&nbsp;<b><i>"Stock Unit</i></b><i>" means</i> an award of a phantom unit representing a share of Company Stock, as described in Section 8.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 3</b>&#8212;<b>ADMINISTRATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.1</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>Committee</b>. The Plan shall be administered and interpreted by the Committee. Ministerial functions may be performed by an administrative committee comprised of Company employees appointed by the Committee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.2</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>Committee Authority</b>. The Committee shall have the sole authority to (i) determine the Participants to whom Grants shall be made under the Plan, (ii) determine the type, size and terms and conditions of the Grants to be made to each such Participant, (iii) determine the time when the Grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and the acceleration of exercisability, (iv) amend the terms and conditions of any previously issued Grant, subject to the provisions of Section 18, and (v) deal with any other matters arising under the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.3</b>&nbsp; &nbsp; &nbsp;<b>Committee Determinations.</b> The Committee shall have full power and express discretionary authority to administer and interpret the Plan, to make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for the conduct of its business as it deems necessary or advisable, in its sole discretion. Without limiting the generality of the preceding sentence, the Committee shall have the exclusive right to: (i) interpret the Plan and the Grant Agreements executed hereunder; (ii) decide all questions concerning eligibility for, and the amount of, Grants awarded under the Plan; (iii) construe any ambiguous provision of the Plan or any Grant Agreement; (iv) prescribe the form of Grant Agreements; (v) correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Grant Agreement; (vi) issue administrative guidelines as an aid to administering the Plan and make changes in such guidelines as the Committee from time to time deems proper; (vii) make regulations for carrying out the Plan and make changes in such regulations as the Committee from time to time deems proper; (viii) determine whether Grants should be awarded singly or in combination; (ix) to the extent permitted under the Plan, grant waivers of Plan terms, conditions, restrictions and limitations; (x) accelerate the exercise, vesting or payment of a Grant when such action or actions would be in the best interests of the Company; (xi) require Participants to hold a stated number or percentage of shares of Common Stock acquired pursuant to a Grant for a stated period; and (xii) take any and all other actions the Committee deems necessary or advisable for the proper operation or administration of the Plan. The decisions of the Committee and its actions with respect to the Plan shall be final, conclusive and binding on all persons having or claiming to have any right or interest in or under the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>3.4</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>Liability; Indemnification</b>. No member of the Committee, nor any person to whom it has delegated authority, shall be personally liable for any action, interpretation or determination made in good faith with respect to the Plan or Grants awarded hereunder, and each member of the Committee (or delegatee of the Committee) shall be fully indemnified and protected by the Company with respect to any liability he may incur with respect to any such action, interpretation or determination, to the maximum extent permitted by applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 4</b>&#8212;<b>GRANTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Grants under the Plan may consist of Options as described in Section 7, Stock Units as described in Section 8, Stock Awards as described in Section 9, SARs as described in Section 10 and Other Stock-Based Awards as described in Section 11. All Grants shall be subject to such terms and conditions as the Committee deems appropriate and as are specified in writing by the Committee to the Participant in the Grant Agreement. By acceptance of the Grant, a Participant acknowledges that all decisions and determinations of the Committee shall be final and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such Grant. Grants under a particular Section of the Plan need not be uniform as among the Participants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Notwithstanding the Committee's discretion granted under the Plan to determine the vesting provisions applicable to a Grant, the vesting provisions shall, in all events, be subject to the provisions of this Section 4. Grants are subject to a minimum vesting period of one year from the date of grant; provided, however, that the Company may issue shares of Common Stock with a vesting period less than one year up to an amount equaling five percent (5%) of the total shares authorized to be issued under the Plan pursuant to Section 5.1 hereof. Notwithstanding the foregoing, the Grant Agreement may provide for vesting to occur upon the Participant&#8217;s death, Disability or retirement or, subject to the limitations contained herein, in the event of a Change in Control.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: small-caps; margin: 0pt; text-align: center;"><b>Section 5</b>&#8212;<b>SHARES SUBJECT TO PLAN</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.1</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Shares Authorized</b>. Subject to adjustment as described below in Section 5.4, the total aggregate number of shares of Company Stock that may be issued or transferred under the Plan shall be the sum of the following: (i) the number of shares of Company Stock subject to outstanding grants under the 2005 and 2015Plans as of the Effective Date (reverting to shares reserved for future grant as and when described in Section 5.2 below), plus (ii) the number of shares of Company Stock remaining available for issuance under the 2005 and 2015 Plans but not subject to an outstanding award and not previously exercised, vested or paid as of the Effective Date (as adjusted for the Company&#8217;s 2016 stock split), plus (iii) 1,000,000 shares. The maximum aggregate number of shares of Company Stock with respect to which all Grants of Incentive Stock Options may be made under the Plan shall be 1,000,000 shares, subject to adjustment as described below in Section 5.4.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.2</b>&nbsp;&nbsp;&nbsp; &nbsp;<b>Source of Shares; Share Counting</b>. Shares issued or transferred under the Plan may be authorized but unissued shares of Company Stock or reacquired shares of Company Stock, including shares purchased by the Company on the open market for purposes of the Plan. If and to the extent Options or SARs granted under the Plan (including options granted under the 2005 and 2015 Plans) terminate, expire, or are canceled, forfeited, exchanged or surrendered without having been exercised, and if and to the extent that any Stock Awards, Stock Units, or Other Stock-Based Awards (including stock awards and stock units granted under the 2005 and 2015 Plans) are forfeited or terminated, or otherwise are not paid in full, the shares reserved for such Grants shall again be available for purposes of the Plan. If shares of Company Stock otherwise issuable under the Plan are surrendered in payment of the Exercise Price of an Option, then the number of shares of Company Stock available for issuance under the Plan shall be reduced by the gross number of shares as to which such Option is exercised. If shares of Company Stock otherwise issuable under the Plan are withheld by the Company in satisfaction of the withholding taxes incurred in connection with the issuance, vesting or exercise of any Grant or the issuance of Company Stock thereunder, then the number of shares of Company Stock available for issuance under the Plan shall be reduced by the number of shares issued, vested or exercised under such Grant, calculated in each instance before payment of such share withholding. Upon the exercise of a SAR, then both for purposes of calculating the number of shares of Company Stock remaining available for issuance under the Plan and the number of shares of Company Stock remaining available for exercise under such SAR, the number of such shares shall be reduced by the net number of shares for which the SAR is exercised, and without regard to any cash settlement of a SAR. To the extent that any Grants are paid in cash (including grants under the 2005 and 2015 Plans), and not in shares of Company Stock, such Grants shall not count against the share limits in Section 5.1.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.3</b>&nbsp;&nbsp;&nbsp; &nbsp;<b>Individual Limits</b>. All Grants under the Plan shall be expressed in shares of Company Stock. The maximum aggregate value of all Grants that may be awarded under the Plan during any calendar year to any Non-Employee Director shall be $100,000 (provided, however, that such limits do not apply to cash-based directors fees which directors elect to have paid in Common Stock instead). For purposes of applying the limit in the preceding sentence, any shares of Company Stock awarded shall be valued at the grant date fair value computed in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718, Compensation-Stock Compensation. The individual limits of this Section 5.3 shall apply without regard to whether the Grants are to be paid in Company Stock or cash. All cash payments (other than with respect to Dividend Equivalents) shall equal the Fair Market Value of the shares of Company Stock to which the cash payments relate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>5.4</b>&nbsp; &nbsp;&nbsp; &nbsp;<b>Adjustments</b>. If there is any change in the number or kind of shares of Company Stock outstanding (i) by reason of a stock dividend, spinoff, recapitalization, stock split, or combination or exchange of shares, (ii) by reason of a merger, reorganization or consolidation, (iii) by reason of a reclassification or change in par value, or (iv) by reason of any other extraordinary or unusual event affecting the outstanding Company Stock as a class without the Company's receipt of consideration, or if the value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or the Company's payment of an extraordinary dividend or distribution, the maximum number of shares of Company Stock available for issuance under the Plan, the maximum number of shares of Company Stock for which any individual may receive Grants in any year, the kind and number of shares covered by outstanding Grants, the kind and number of shares issued or transferred and to be issued or transferred under the Plan, and the price per share or the applicable market value of such Grants shall be equitably adjusted by the Committee, in such manner as the Committee deems appropriate, to reflect any increase or decrease in the number of, or change in the kind or value of, the issued shares of Company Stock to preclude, to the extent practicable, the enlargement or dilution of rights and benefits under the Plan and such outstanding Grants; provided, however, that any fractional shares resulting from such adjustment shall be eliminated. In addition, in the event of a Change of Control of the Company, the provisions of Section 16 of the Plan shall apply. Any adjustments to outstanding Grants shall be consistent with section 409A or 424 of the Code, to the extent applicable. Any adjustments determined by the Committee shall be final, binding and conclusive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 6</b>&#8212;<b>ELIGIBILITY FOR PARTICIPATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>6.1</b>&nbsp; &nbsp;&nbsp; &nbsp;<b>Eligible Persons</b>. All Employees and Non-Employee Directors shall be eligible to participate in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>6.2</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>Selection of Participants</b>. The Committee shall select the Employees and Non-Employee Directors to receive Grants and shall determine the number of shares of Company Stock subject to each Grant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 7</b>&#8212;<b>OPTIONS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.1</b>&nbsp;&nbsp; &nbsp;&nbsp;<b>General Requirements</b>. The Committee may grant Options to an Employee or Non-Employee Director upon such terms and conditions as the Committee deems appropriate under this Section 7. The Committee shall determine the number of shares of Company Stock that will be subject to each Grant of Options to Employees and Non-Employee Directors.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.2</b>&nbsp;&nbsp; &nbsp; &nbsp;<b>Type of Option, Price and Term</b>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(a)&nbsp; &nbsp; &nbsp; The Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms and conditions set forth herein. Incentive Stock Options may be granted only to Employees of the Company or its parents or subsidiaries, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to Employees or Non-Employee Directors.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp; &nbsp; The Exercise Price of Company Stock subject to an Option shall be determined by the Committee and may be equal to or greater than the Fair Market Value of a share of Company Stock on the date the Option is granted. However, an Incentive Stock Option may not be granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary, as defined in section 424 of the Code, unless the Exercise Price per share is not less than 110% of the Fair Market Value of the Company Stock on the date of grant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(c)&nbsp; &nbsp; &nbsp; The Committee shall determine the term of each Option, which shall not exceed ten years from the date of grant. However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary, as defined in section 424 of the Code, may not have a term that exceeds five years from the date of grant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.3</b>&nbsp;&nbsp; &nbsp; &nbsp;<b>Exercisability of Options</b>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp; &nbsp;Options shall become exercisable in accordance with such terms and conditions as may be determined by the Committee and specified in the Grant Agreement. The Committee may grant Options that are subject to achievement of performance goals or other conditions. The Committee may accelerate the exercisability of any or all outstanding Options at any time for any reason.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Options granted to persons who are non-exempt employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such Options may become exercisable, as determined by the Committee, upon the Participant's death, Disability or retirement, or upon a Change of Control or other circumstances permitted by applicable regulations).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.4</b>&nbsp; &nbsp;&nbsp;&nbsp;<b>Termination of Employment or Service</b>. Except as provided in the Grant Agreement, an Option may only be exercised while the Participant is employed as an Employee or providing service as a Non-Employee Director. The Committee shall determine in the Grant Agreement under what circumstances and during what time periods a Participant may exercise an Option after termination of employment or service.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.5</b>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<b>Exercise of Options.</b> A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise to the Company. The Participant shall pay the Exercise Price for the Option (i) in cash, (ii) if permitted by the Committee, by delivering shares of Company Stock owned by the Participant and having a Fair Market Value on the date of exercise equal to the Exercise Price or by attestation to ownership of shares of Company Stock having an aggregate Fair Market Value on the date of exercise equal to the Exercise Price, (iii) by payment through a broker in accordance with procedures permitted by Regulation T (or other applicable regulations) of the Federal Reserve Board, (iv) with approval of the Committee, by surrender of all or any part of the vested shares of Company Stock for which the Option is exercisable to the Company for an appreciation distribution payable in shares of Company Stock with a Fair Market Value at the time of the Option surrender equal to the dollar amount by which the then Fair Market Value of the shares of Company Stock subject to the surrendered portion exceeds the aggregate Exercise Price payable for those shares, or (v) by such other method as the Committee may approve, to the extent permitted by applicable law, including without limitation, (A) if there is a public market for the shares of Common Stock at such time, by means of a broker-assisted &#8220;cashless exercise&#8221; pursuant to which the Company is delivered (including telephonically to the extent permitted by the Committee) a copy of irrevocable instructions to a stockbroker to sell the shares of Common Stock otherwise issuable upon the exercise of the Option and to deliver promptly to the Company an amount equal to the Exercise Price; or (B) a &#8220;net exercise&#8221; procedure effected by withholding the minimum number of shares of Common Stock otherwise issuable in respect of an Option that are needed to pay the Exercise Price. Shares of Company Stock used to exercise an Option shall have been held by the Participant for the requisite period of time to avoid adverse accounting consequences to the Company with respect to the Option. Payment for the shares pursuant to the Option, and any required withholding taxes, must be received by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance of the Company Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>7.6</b>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;<b>Limits on Incentive Stock Options</b>. Each Incentive Stock Option shall provide that, if the aggregate Fair Market Value of the stock on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year, under the Plan or any other stock option plan of the Company or a parent or subsidiary, as defined in section 424 of the Code, exceeds $100,000, then the Option, as to the excess, shall be treated as a Nonqualified Stock Option. An Incentive Stock Option shall not be granted to any person who is not an Employee of the Company or a parent or subsidiary, as defined in section 424 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 8</b>&#8212;<b>STOCK UNITS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.1</b>&nbsp; &nbsp; &nbsp;<b>General Requirements</b>. The Committee may grant Stock Units to an Employee or Non-Employee Director, upon such terms and conditions as the Committee deems appropriate under this Section 8. Each Stock Unit shall represent the right of the Participant to receive a share of Company Stock or an amount based on the value of a share of Company Stock. All Stock Units shall be credited to bookkeeping accounts on the Company's records for purposes of the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.2</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>Terms of Stock Units</b>. The Committee may grant Stock Units that are payable on terms and conditions determined by the Committee, which may include payment based on achievement of performance goals. Stock Units may be paid at the end of a specified vesting or performance period, or payment may be deferred to a date authorized by the Committee. The Committee shall determine the number of Stock Units to be granted and the requirements applicable to such Stock Units.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.3&nbsp;</b>&nbsp; &nbsp;&nbsp;<b>Payment With Respect to Stock Units</b>. Payment with respect to Stock Units shall be made in cash, in Company Stock, or in a combination of the two, as determined by the Committee. The Grant Agreement shall specify the maximum number of shares that can be issued under the Stock Units.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.4</b>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;<b>Requirement of Employment or Service</b>. The Committee shall determine in the Grant Agreement under what circumstances a Participant may retain Stock Units after termination of the Participant's employment or service, and the circumstances under which Stock Units may be forfeited.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>8.5</b>&nbsp;&nbsp;&nbsp; &nbsp;<b>Dividend</b> <b>Equivalents.</b> The Committee may grant Dividend Equivalents in connection with Stock Units, under such terms and conditions as the Committee deems appropriate.&nbsp; Dividend Equivalents awarded with respect to unvested Stock Units will be accumulated and paid to Participants at the time that such Stock Units vest, and will be forfeited in the event the underlying Stock Units are forfeited. All Dividend Equivalents shall be credited to bookkeeping accounts on the Company&#8217;s records for purposes of the Plan.&nbsp; Dividend Equivalents may be accrued as a cash obligation, or may be converted to additional Stock Units for the Participant, and deferred cash Dividend Equivalents may accrue interest, all as determined by the Committee.&nbsp; The Committee may provide that Dividend Equivalents shall be credited based on the achievement of specific performance goals.&nbsp; Dividend Equivalents may be payable in cash or shares of Company Stock or in a combination of the two, as determined by the Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 9</b>&#8212;<b>STOCK AWARDS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.1</b>&nbsp; &nbsp; &nbsp;<b>General Requirements</b>. The Committee may issue shares of Company Stock to an Employee or Non-Employee Director under a Stock Award, upon such terms and conditions as the Committee deems appropriate under this Section 9. Shares of Company Stock issued pursuant to Stock Awards may be issued for cash consideration or for no cash consideration, and subject to restrictions or no restrictions, as determined by the Committee. The Committee may establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such other criteria as the Committee deems appropriate, including restrictions based upon the achievement of specific performance goals. The Committee shall determine the number of shares of Company Stock to be issued pursuant to a Stock Award.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.2</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>Requirement of Employment or Service</b>. The Committee shall determine in the Grant Agreement under what circumstances a Participant may retain Stock Awards after termination of the Participant's employment or service, and the circumstances under which Stock Awards may be forfeited.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.3</b>&nbsp; &nbsp; &nbsp;&nbsp;<b>Restrictions on Transfer</b>. While Stock Awards are subject to restrictions, a Participant may not sell, assign, transfer, pledge or otherwise dispose of the shares of a Stock Award except upon death as described in Section 15.1. If certificates are issued, each certificate for a share of a Stock Award shall contain a legend giving appropriate notice of the restrictions in the Grant. The Participant shall be entitled to have the legend removed when all restrictions on such shares have lapsed. The Company may retain possession of any certificates for Stock Awards until all restrictions on such shares have lapsed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>9.4</b>&nbsp; &nbsp; &nbsp;<b>Right to Vote and to Receive Dividends</b>. The Committee shall determine to what extent, and under what conditions, the Participant shall have the right to vote shares of Stock Awards and to receive any dividends or other distributions paid on such shares during the restriction period, provided that no such dividends shall be paid with respect to unvested Stock Awards, including Stock Awards subject to performance goals, until and unless the related Stock Awards are vested. Dividends awarded with respect to unvested Stock Awards will be accumulated and paid to the Participant at the time that such Stock Award vests, and will be forfeited in the event the underlying Stock Award is forfeited. Dividends that are not paid currently shall be credited to bookkeeping accounts on the Company&#8217;s records for purposes of the Plan.&nbsp; Dividends so accumulated may be payable in cash or shares of Company Stock or in a combination of the two, as determined by the Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 10</b>&#8212;<b>STOCK APPRECIATION RIGHTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.1</b>&nbsp; &nbsp; <b>General Requirements</b>. The Committee may grant SARs to an Employee or Non-Employee Director separately or in tandem with an Option. The Committee shall establish the number of shares, the terms and the base amount of the SAR at the time the SAR is granted. The base amount of each SAR shall be not less than the Fair Market Value of a share of Company Stock as of the date of grant of the SAR.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.2</b>&nbsp;&nbsp; &nbsp;<b>Tandem SARs</b>. The Committee may grant tandem SARs either at the time the Option is granted or at any time thereafter while the Option remains outstanding; provided, however, that, in the case of an Incentive Stock Option, SARs may be granted only at the date of the grant of the Incentive Stock Option. In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable during a specified period shall not exceed the number of shares of Company Stock that the Participant may purchase upon the exercise of the related Option during such period. Upon the exercise of an Option, the SARs relating to the Company Stock covered by such Option shall terminate. Upon the exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Company Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.3</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Exercisability; Term</b>. A SAR shall become exercisable in accordance with such terms and conditions as may be specified in a Grant Agreement. The Committee may grant SARs that are subject to achievement of performance goals or other conditions. The Committee may accelerate the exercisability of any or all outstanding SARs at any time for any reason. The Committee shall determine in the Grant Agreement under what circumstances and during what periods a Participant may exercise a SAR after termination of employment or service. A tandem SAR shall be exercisable only while the Option to which it is related is exercisable. The Committee shall determine the term of each SAR, which shall not exceed ten years from the date of grant.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.4</b>&nbsp; &nbsp;&nbsp;<b>Grants to Non-Exempt Employees</b>. SARs granted to persons who are non-exempt employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of grant (except that such SARs may become exercisable, as determined by the Committee, upon the Participant's death, Disability or retirement, or upon a Change of Control or other circumstances permitted by applicable regulations).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.5</b>&nbsp; &nbsp;&nbsp;<b>Exercise of SARs</b>. When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an amount equal to the value of the stock appreciation for the number of SARs exercised. The stock appreciation for a SAR is the amount by which the Fair Market Value of the underlying Company Stock on the date of exercise of the SAR exceeds the base amount of the SAR as specified in the Grant Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>10.6</b>&nbsp; &nbsp;&nbsp;<b>Form of Payment</b>. The Committee shall determine whether the stock appreciation for a SAR shall be paid in the form of shares of Company Stock, cash or a combination of the two. For purposes of calculating the number of shares of Company Stock to be received, shares of Company Stock shall be valued at their Fair Market Value on the date of exercise of the SAR. If shares of Company Stock are to be received upon exercise of a SAR, cash shall be delivered in lieu of any fractional share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 11</b>&#8212;<b>OTHER STOCK-BASED AWARDS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Committee may grant other awards not specified in Sections 7, 8, 9 or 10 above that are based on or measured by Company Stock to Employees or Non-Employee Directors, on such terms and conditions as the Committee deems appropriate.&nbsp; Other Stock-Based Awards may be granted subject to achievement of performance goals or other conditions and may be payable in Company Stock or cash, or in a combination of the two, as determined by the Committee in the Grant Agreement. Dividends and Dividend Equivalents may accrue with respect to unvested Other Stock-Based Awards, but will not be paid or issued until such Stock-Based Award is fully vested, the shares are issued to the Participant and such shares are no longer subject to any vesting requirements, holding periods or repurchase rights on behalf of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 12</b>&#8212;<b>PERFORMANCE-BASED COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.1</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Performance-Based Compensation</b>. The Committee may determine that Stock Units, Stock Awards, Dividend Equivalents or Other Stock-Based Awards granted to an Employee shall be subject to objective performance-based criteria as defined in this Section 12.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.2</b>&nbsp; &nbsp;&nbsp;<b>Performance Criteria</b>. When Grants are made under this Section 12, the Committee shall establish in writing (i) the Performance Criteria that must be met, (ii) the period during which performance will be measured, (iii) the maximum amounts that may be paid if the Performance Criteria are met, and (iv) any other conditions that the Committee deems appropriate and consistent with the requirements of applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.3</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Performance Criteria</b>. The Committee may establish performance goals based on, among other things, one or more of the following criteria for the Company or any business unit, division, department or any combination of these and may be applied on an absolute basis and/or relative to one or more peer group companies or indices, or any combination thereof, as the Committee shall determine:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(a)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">earnings or earnings per share (whether on a pre-tax, after-tax, operational or other basis, diluted or undiluted, and before or after adjustments for extraordinary items and business combination acquisition and restructuring costs);</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(b)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">return on equity;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(c)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">return on assets;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(d)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">net or gross revenues or revenue growth over prior year or as compared to budget;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(e)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">expenses or expense levels;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(f)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">one or more operating ratios;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(g)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">stock price (including, but not limited to, growth measures and total shareholder return);</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(h)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">stockholder return;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(i)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">the accomplishment of mergers, acquisitions, dispositions, public offerings or similar extraordinary business transactions;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(j)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">economic value added;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(k)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">net or gross income or income growth over prior year or as compared to budget, which, if determined for a department or business unit, may be determined solely with reference to direct costs of that department or business unit; or</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">(l)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">such combination of the foregoing performance-based criteria as the Committee shall determine in its sole discretion (together, the "<b><i>Performance Criteria</i></b>").</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Such performance goals also may be based on the achievement of specified levels of Company performance (or performance of an applicable affiliate, division or business unit of the Company) under one or more of the Performance Criteria described above relative to the Company's past performance or performance of other corporations. Such performance goals shall be set by the Committee over a specified performance period that shall not be shorter than one year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.4</b>&nbsp; &nbsp; &nbsp;<b>Timing of Establishment of Criteria</b>. Performance Criteria must be pre-established by the Committee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.5</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Certification of Results</b>. The Committee shall certify the performance results for the performance period specified in the Grant Agreement after the performance period ends. The Committee shall determine the amount, if any, to be paid pursuant to each Grant based on the achievement of the performance goals and the satisfaction of all other terms of the Grant Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>12.6</b>&nbsp;&nbsp; &nbsp;<b>Death, Disability or Other Circumstances</b>. The Committee may provide in the Grant Agreement that Grants under this Section 12 shall be payable, in whole or in part, in the event of the Participant's death, Disability, or a Change of Control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 13</b>&#8212;<b>DEFERRALS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would otherwise be due to the Participant in connection with any Grant. The Committee shall establish rules and procedures for any such deferrals, consistent with applicable requirements of section 409A of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 14</b>&#8212;<b>WITHHOLDING OF TAXES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>14.1</b>&nbsp;&nbsp; &nbsp;<b>Required Withholding</b>. All Grants under the Plan shall be subject to applicable federal (including FICA), state and local tax withholding requirements. The Company may require that the Participant or other person receiving or exercising Grants pay to the Company the amount of any federal, state or local taxes that the Company is required to withhold with respect to such Grants, or the Company may deduct from other wages paid by the Company the amount of any withholding taxes due with respect to such Grants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>14.2</b>&nbsp;&nbsp; &nbsp;<b>Election to Withhold Shares</b>. If the Committee so permits, shares of Company Stock may be withheld to satisfy the Company's tax withholding obligation with respect to Grants paid in Company Stock at the time such Grants become taxable, up to an amount that does not exceed the minimum applicable withholding tax rate for federal (including FICA), state and local tax liabilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 15</b>&#8212;<b>TRANSFERABILITY OF GRANTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>15.1</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Restrictions on Transfer</b>. Except as described in Section 15.2 below, only the Participant may exercise rights under a Grant during the Participant's lifetime, and a Participant may not transfer those rights except by will or by the laws of descent and distribution or pursuant to a qualified domestic relations order. When a Participant dies, the personal representative or other person entitled to succeed to the rights of the Participant may exercise such rights. Any such successor must furnish proof satisfactory to the Company of his or her right to receive the Grant under the Participant's will or under the applicable laws of descent and distribution.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>15.2</b>&nbsp;&nbsp;&nbsp;<b>Transfer of Nonqualified Stock Options to or for Family Members</b>. Notwithstanding the foregoing, the Committee may provide in a Grant Agreement that a Participant may transfer Nonqualified Stock Options to family members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with applicable securities laws, according to such terms as the Committee may determine; provided that the Participant receives no consideration for the transfer of a Nonqualified Stock Option and the transferred Nonqualified Stock Option shall continue to be subject to the same terms and conditions as were applicable to the Nonqualified Stock Option immediately before the transfer. For purposes of this Section 15.2, &#8220;family members&#8221; shall have the meaning given to that term in Form S-8 adopted by the Securities and Exchange Commission under the 1933 Act, as such form may be modified or amended from time to time, or any successor form.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 16</b>&#8212;<b>CONSEQUENCES OF A CHANGE OF CONTROL</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>16.1</b>&nbsp;&nbsp;&nbsp;<b>Acceleration</b>. Upon a termination of employment of a Participant occurring in connection with or during a period of two years following a Change of Control, except as otherwise set forth in the Grant Agreement, (i) all outstanding Options and SARs of that Participant shall automatically accelerate and become fully exercisable, (ii) the restrictions and conditions on all outstanding Stock Awards for that Participant shall immediately lapse, and (iii) all Stock Units, Other Stock-Based Awards and Dividend Equivalents shall become fully vested and shall be paid to the Participant at the greater of their target values or the actual level of achievement through the employment termination date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>16.2</b>&nbsp; &nbsp;&nbsp;<b>Other Alternatives</b>. In the event of a Change of Control, the Committee may also take one or more of the following actions with respect to any or all outstanding Grants: the Committee may (i) require that Participants surrender their outstanding Options and SARs in exchange for one or more payments by the Company, in cash or Company Stock as determined by the Committee, in an amount equal to the amount by which the then Fair Market Value of the shares of Company Stock subject to the Participant's unexercised Options and SARs exceeds the Exercise Price of the Options or the base amount of the SARs, as applicable, (ii) after giving Participants an opportunity to exercise their outstanding Options and SARs, terminate any or all unexercised Options and SARs at such time as the Committee deems appropriate, or (iii) determine that outstanding Options and SARs that are not exercised shall be assumed by, or replaced with comparable options or rights by, the surviving corporation, (or a parent or subsidiary of the surviving corporation), and other outstanding Grants that remain in effect after the Change of Control shall be converted to similar grants of the surviving corporation (or a parent or subsidiary of the surviving corporation). Such surrender or termination shall take place as of the date of the Change of Control or such other date as the Committee may specify.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 17</b>&#8212;<b>REQUIREMENTS FOR ISSUANCE OF SHARES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>17.1 </b>&nbsp; <b>Issuance Requirements.</b> No Company Stock shall be issued in connection with any Grant hereunder unless and until all legal requirements applicable to the issuance of such Company Stock have been complied with to the satisfaction of the Committee. The Committee shall have the right to condition any Grant made to any Participant hereunder on such Participant's undertaking in writing to comply with such restrictions on his or her subsequent disposition of such shares of Company Stock as the Committee shall deem necessary or advisable, including but not limited to the requirements imposed by the Company&#8217;s Compensation Recoupment Policy, as amended from time to time, or any successor policy, and certificates representing such shares may be legended to reflect any such restrictions. Certificates representing shares of Company Stock issued under the Plan will be subject to such stop-transfer orders and other restrictions as may be required by applicable laws, regulations and interpretations, including any requirement that a legend be placed thereon. No Participant shall have any right as a shareholder with respect to Company Stock covered by a Grant until shares have been issued to the Participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>17.2</b>&nbsp; &nbsp;&nbsp;<b>Clawback/Forfeiture</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All Grants shall be subject to reduction, cancellation, forfeiture or recoupment (i) to the extent necessary to comply with (A) any clawback, forfeiture or other similar policy adopted by the Board or Committee and as in effect from time to time (including the Company&#8217;s Compensation Recoupment Policy, as amended from time to time); and (B) applicable law, including, but not limited to, the applicable rules and regulations of the Securities and Exchange Commission and the NASDAQ Stock Market or any other securities exchange or inter-dealer quotation system on which the Common Stock is listed or quoted, and (ii) as the Committee may specify in a Grant Agreement, upon the occurrence of other specified events, including, without limitation, failure to remit the amounts necessary to satisfy the Participant&#8217;s tax withholding obligations, termination for cause, termination of the Participant&#8217;s provision of services to the Company, violation of material policies of the Company, breach of noncompetition, confidentiality, or other restrictive covenants that may apply to the Participant, or other conduct by the Participant that is detrimental to the business or reputation of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt; text-align: justify;">(b) &nbsp;&nbsp; &nbsp; &nbsp; If the Company is required to prepare an accounting restatement due to the material noncompliance of the Company, as a result of misconduct, with any financial reporting requirement under the securities laws, if the Participant knowingly or grossly negligently engaged in the misconduct, or knowingly or grossly negligently failed to prevent the misconduct, or if the Participant is one of the individuals subject to automatic forfeiture under Section 304 of the Sarbanes-Oxley Act of 2002, the Participant shall, to the extent required by Section 304 of the Sarbanes-Oxley Act of 2002, reimburse the Company the amount of any payment in settlement of a Grant earned or accrued during the twelve (12) month period following the first public issuance or filing with the Securities and Exchange Commission (whichever just occurred) of the financial document embodying such financial reporting requirement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 27pt; text-align: justify;">(c) &nbsp;&nbsp; &nbsp; &nbsp;&nbsp;To the extent that any policy adopted by the Company in order to comply with regulations issued pursuant to Section 10D of the Exchange Act, as required by Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, requires any Participant to forfeit any Grant, or repay any amount paid with respect to any Grant, such policy shall be deemed incorporated into all outstanding Grants to the extent required by such regulations, and all Participants subject to such regulations, by accepting any Grant, shall be deemed to have consented to the inclusion of provisions in their Grant Agreement as determined by the Committee to be necessary or appropriate to comply with such regulations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;text-indent:36pt;"><b>Section 18</b>&#8212;<b>AMENDMENT OF THE PLAN</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>18.1</b>&nbsp; &nbsp;&nbsp;<b>Amendment</b>. The Board may amend or terminate the Plan at any time; provided, however, that the Board shall not amend the Plan without approval of the shareholders of the Company if such approval is required in order to comply with the Code or applicable laws, or to comply with applicable stock exchange requirements. No amendment or termination of this Plan shall, without the consent of the Participant, materially impair any rights or obligations under any Grant previously made to the Participant under the Plan, unless such right has been reserved in the Plan or the Grant Agreement, or except as provided in Section 19.2 below. Notwithstanding anything in the Plan to the contrary, the Board may amend the Plan in such manner as it deems appropriate in the event of a change in applicable law or regulations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>18.2</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>No Repricing Without Shareholder Approval</b>. Notwithstanding anything in the Plan to the contrary, except as authorized by Section 5.4, no amendment or modification of any outstanding Grant may reduce the exercise price of any Option or the base amount of any SAR; (ii) the Committee may not cancel any outstanding Option or SAR and replace it with a new Option or SAR (with a lower exercise price or base amount, as the case may be) or other Grant or cash payment that is greater than the intrinsic value (if any) of the cancelled Option or SAR and (iii) the Committee may not take any other action which is considered a &#8220;repricing&#8221; for purposes of the shareholder approval rules of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or quoted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>Section 19</b>&#8212;<b>MISCELLANEOUS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>19.1</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Effective Date</b>. The Plan shall be effective as of the Effective Date, if approved by the Company's shareholders on such date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.2</b>&nbsp; &nbsp;&nbsp;<b>Grants in Connection with Corporate Transactions and Otherwise</b>. Nothing contained in this Plan shall be construed to (i) limit the right of the Committee to make Grants under this Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of the business or assets of any corporation, firm or association, including Grants to employees thereof who become Employees, or for other proper corporate purposes, or (ii) limit the right of the Company to grant stock options or SARs or make other stock-based awards outside of this Plan. Without limiting the foregoing, the Committee may make a Grant to an employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property, reorganization or liquidation involving the Company in substitution for a grant made by such corporation. The terms and conditions of the Grants may vary from the terms and conditions required by the Plan and from those of the substituted stock incentives, as determined by the Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>19.3</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Compliance with Law</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">(a)&nbsp; &nbsp; &nbsp; The Plan, the exercise of Options and the obligations of the Company to issue or transfer shares of Company Stock under Grants shall be subject to all applicable laws and to approvals by any governmental or regulatory agency as may be required. With respect to persons subject to section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In addition, it is the intent of the Company that Incentive Stock Options comply with the applicable provisions of section 422 of the Code. To the extent that any legal requirement of section 16 of the Exchange Act or section 422 of the Code as set forth in the Plan ceases to be required under section 16 of the Exchange Act or section 422 of the Code, that Plan provision shall cease to apply. The Committee may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory government regulation. The Committee may also adopt rules regarding the withholding of taxes on payments to Participants. The Committee may, in its sole discretion, agree to limit its authority under this Section.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">(b)&nbsp; &nbsp;&nbsp; &nbsp;The Plan is intended to comply with the requirements of section 409A of the Code such that Grants hereunder will be exempt therefrom, or if not so exempt, will comply with that section so as not to impose taxes on Participants prior to the receipt of value hereunder. Each Grant shall be construed and administered such that the Grant either (A) qualifies for an exemption from the requirements of section 409A of the Code or (B) satisfies the requirements of section 409A of the Code. If a Grant is subject to section 409A of the Code, (i) distributions shall only be made in a manner and upon an event permitted under section 409A of the Code, (ii) payments to be made upon a termination of employment shall only be made upon a "separation from service" under section 409A of the Code, (iii) unless the Grant specifies otherwise, each installment payment shall be treated as a separate payment for purposes of section 409A of the Code, and (iv) in no event shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with section 409A of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">(c)&nbsp; &nbsp; &nbsp; &nbsp;Any Grant that is subject to section 409A of the Code and that is to be distributed to a Key Employee (as described below) upon separation from service shall be administered so that any distribution with respect to such Grant shall be postponed for six months following the date of the Participant's separation from service, if required by section 409A of the Code. If a distribution is delayed pursuant to section 409A of the Code, the distribution shall be paid within 15 days after the end of the six-month period. If the Participant dies during such six-month period, any postponed amounts shall be paid within 90 days of the Participant's death. The determination of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by the Committee or its delegate each year in accordance with section 416(i) of the Code and the "specified employee" requirements of section 409A of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">(d)&nbsp; &nbsp; &nbsp; &nbsp;Notwithstanding anything in the Plan or any Grant agreement to the contrary, each Participant shall be solely responsible for the tax consequences of Grants under the Plan, and in no event shall the Company have any responsibility or liability if a Grant does not meet any applicable requirements of section 409A of the Code. Although the Company intends to administer the Plan to prevent taxation under section 409A or other section of the Code, the Company does not represent or warrant that the Plan or any Grant complies with any provision of federal, state, local or other tax law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.4</b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Enforceability</b>. The Plan shall be binding upon and enforceable against the Company and its successors and assigns.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.5</b>&nbsp; &nbsp;<b>Funding of the Plan; Limitation on Rights</b>. This Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any other segregation of assets to assure the payment of any Grants under this Plan. Nothing contained in the Plan and no action taken pursuant hereto shall create or be construed to create a fiduciary relationship between the Company and any Participant or any other person. No Participant or any other person shall under any circumstances acquire any property interest in any specific assets of the Company. To the extent that any person acquires a right to receive payment from the Company hereunder, such right shall be no greater than the right of any unsecured general creditor of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.6</b>&nbsp; &nbsp;&nbsp;<b>Rights of Participants</b>. Nothing in this Plan shall entitle any Employee, Non-Employee Director, or other person to any claim or right to receive a Grant under this Plan. Neither this Plan nor any action taken hereunder shall be construed as giving any individual any rights to be retained by or in the employment or service of the Employer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.7</b>&nbsp; &nbsp;&nbsp;<b>No Fractional Shares</b>. No fractional shares of Company Stock shall be issued or delivered pursuant to the Plan or any Grant. The Committee shall determine whether cash, other awards or other property shall be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.8&nbsp;</b>&nbsp;&nbsp;&nbsp;<b>Clawback Rights</b>. All Grants under the Plan will be subject to the requirements of Section 17.2 hereof, and any other compensation, clawback and recoupment policies that may be applicable to the employees of the Company, as in effect from time to time and as approved by the Board or Committee, whether or not approved before or after the Effective Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.9</b>&nbsp; &nbsp;&nbsp;<b>Data Protection.</b> By participating in the Plan or accepting any rights granted under it, each Participant consents to the collection and processing of personal data relating to the Participant so that the Company can fulfill their obligations and exercise their rights under the Plan and generally administer and manage the Plan. This data will include, but may not be limited to, data about participation in the Plan and shares offered or received, purchased, or sold under the Plan from time to time and other appropriate financial and other data (such as the date on which the Awards were granted) about the Participant and his or her participation in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>19.10&nbsp;</b>&nbsp;<b>Governing Law</b>. The validity, construction, interpretation and effect of the Plan and Grant Agreements issued under the Plan shall be governed and construed by and determined in accordance with the laws of the Commonwealth of Kentucky, without giving effect to the conflict of laws provisions thereof.<b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>IN WITNESS WHEREOF</b>, this Plan has been executed as of the Effective Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>STOCK YARDS BANCORP, INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">By:</p>
			</td>
			<td style="width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">/s/ James A. Hillebrand</p>
			</td>
			<td style="width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Title:</p>
			</td>
			<td style="width: 65%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Chairman and CEO</p>
			</td>
			<td style="width: 30%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">19</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>sybt-20240425.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/1/2024 4:57:26 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:sybt="http://www.sybt.com/20240425" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sybt.com/20240425">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sybt-20240425_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sybt-20240425_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sybt-20240425_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.sybt.com/20240425/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="sybt_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>sybt-20240425_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/1/2024 4:57:26 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.sybt.com/20240425/role/statement-document-and-entity-information" xlink:href="sybt-20240425.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.sybt.com/20240425/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sybt-20240425_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/1/2024 4:57:26 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sybt-20240425_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/1/2024 4:57:26 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.sybt.com/20240425/role/statement-document-and-entity-information" xlink:href="sybt-20240425.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.sybt.com/20240425/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140370055542992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 25, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">STOCK YARDS BANCORP, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Apr. 25,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-13661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">61-1137529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">1040 East Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">40206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-2571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYBT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000835324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MEX\(1;N@:)]),>5:*%> $8$RK@3"I8JRJZN[3L'6.:L;)S)4.E4Z+[P+,K.
M1Y0F8Y5)J[=PC"IQ<?7'-P2Q6R!VST)\$#$GSUFRX+J*!!?Q_> R:'8Z 0+4
M*X!Z9P'-V2>91-"Q8BG"W8@]C8=+=H N:';;]!KANR[XKL_B&T41C'M3G)#<
M3EYD94?BDH'?\LD],Y9\@2D0RD.#$R.H@5\:L_]]L&/GS5!Y<[6I]F5<[TEE
MPGR(..88WM&\$7P?7C$RIEI]"!E6)K-&%!T603EE!*C!?\LV5<:RF/PETI/C
MM4:RY5._@\&5TT. VWK>C2-809U&P07:/L5 RBD@P#W\2860D^E:2<P]:D3:
M/7I)VUW,/8)R.@AP$_^JA;5<0F*2))-[ZS"55+C0DL4&+?-R%@APHYZI6(3"
M"KF" 6YAEF)Q)0^N4LM36GZ V_54\\L0TL-A@.7+HCF7$=?D9;D\T7^X7BU9
MZ?T![M3?D$V,R8"L%A"7K04LS3_ K7HN+,R3:DD"^M/B9S+C80;UMJUDPI5<
M?<*<!HOS\!U;XI9>3W%OGFL6N1*;;9.%JBRP&H'9V^T<(REMG>(.?,@*N?\,
MUTRN^,G%:XW0\VAV-_H=8SK: 9QGY_<)URN7IE]!PJZ=3:1,5G9@C6)=4='2
MS2ENQB,H]2@O]X>8K2I1<(%:E-+/*6[%AS2-@4:#LT]@W'V21UZ=(%S+A[]>
ML]VL7DHWCO:;;N_^A;E^,23F2U#SK[K@SGJW'=Y=6)7F6]"%LK"AS4_7G($M
MN ;P?*F4/5RX76WQH\3P/U!+ P04    " #,:J%8GZ ;\+$"  #B#   #0
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ S&JA6 =!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #,
M:J%8YO,N].\    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " #,:J%8F5R<(Q &  "<)P  $P
M@ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,QJH5@"4'G<
M1P0  * 0   8              " @0X(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " #,:J%8GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sybt20240501_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sybt.com/20240425/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>sybt-20240425.xsd</File>
    <File>sybt-20240425_def.xml</File>
    <File>sybt-20240425_lab.xml</File>
    <File>sybt-20240425_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="sybt20240501_8k.htm">sybt20240501_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sybt20240501_8k.htm": {
   "nsprefix": "sybt",
   "nsuri": "http://www.sybt.com/20240425",
   "dts": {
    "schema": {
     "local": [
      "sybt-20240425.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "sybt-20240425_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sybt-20240425_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sybt-20240425_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "sybt20240501_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.sybt.com/20240425/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sybt20240501_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20248K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sybt20240501_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.sybt.com/20240425/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001437749-24-014120-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-014120-xbrl.zip
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M89 3=VC.>*<;X#+Q%S) @XW6+1O!%-Z)Y:$7K-F(C;TKQAT'=C=:^0?N[-&
MW=_:'&QM7F^Y;[+0M+FK/;L_U$/I(D_Z$AAEGE["#2[B@GR;$V1KF,Q[CIM4
M"_G !NR]?/',30ZV.:FN5@;:W;1.KRC4:C6T]::U-^UI;]9I8[LDL[AGS]#:
M:F8#"Z^ OXYU\FEHW ,FI=SF+'NIHL1O=%!&7P'Z49YH;Y&]%JVAT11,\%)K
M8I)"KA74GIEQ8G@>G.;9MIZB3>L*[0AKPFD3SL'M3KN72MP@GMYTY-#/-IZ[
M3J_2^MTH4J)3D<DZ,,:*<P-Q#9,$[_KUF+K6F]S>Y&=+-IFW4CL1:1\7)U%.
MT0CEW.Y&5G26HZD67$=I3=D<[*X,M7=6$L+UEO<'TFR=ARTJP+](S=!N3M(@
M.'*CM.VK8PSN+-<TT::)Y[<Y^.^2,AHF:5*USSXL=\>UJ>I+PXW<Y/8?2M8@
M40T<R7U!MZ/29##N;RHWJK!6X[KW]\5*9_X=ILYA#1F6B<&A!1[<MV^@VD_!
MZL,4RC1&%4VVRI7(D7"%W[*DTB5D29-=@TI7);-TKNT3-IQ)9>=Z)#(#'%[4
MM%/L&)K[ Z/9IIO193<)1O)6H:X*L[^/HZ3 -?RD*F%2FXOER9;V5>F'BND!
MLDQI1Y+-,,'A0^" 23/@A*812D'OQ7:"D[$I_L"%B@OT*"&W(]=G/95U-F,K
MLTVBV."\@ZYMU/$^'3XC-V@<%S5GC]"0ZW/3/C<OEYZ;#3H==$#\7%0OUF/2
MW_GX#&9%D@;[!V& ^ 5P=TB5ISKNT2A92OQ<S&5A/TQJQ/O1<[G>T_:>[NVV
M-M676=ILZ.=])MJKPPS\&0.Y)C06Z<37@B-SDB^,6;#:M^\\:2L,AG6%BHNY
M?>[F$B,[0-=7,DXL%9AA*:*U02Z0"$?9P"$W*/LBQ?!ON(&JV#2J4(6:Y#>$
MC@%7J@)6U3RN99]?J.(:7B 4GG8%%%ADZ!"":Z(KE<4<9P^PF*[:"0888#"^
M&V<(-__#)F@O&S8P,0MX.GZPX^O1G22&S&1/U[.<]06]8''/^!S%,$9BNV1%
M:E3#0$H4/%'@U-[:V-?ZO'6<M[W^NGP\6IJ*EU=J==:JKI>\8\G[JH_UDCNQ
MP07+?F$-,B^:2"Z[)T]=E]UZ%SIVH>T\;>R"*F(,F'\L@-TMV =C.6,:,3!&
M]+=SMDB/BCR-,$D8N1GL6FFJ[H';G<T<MXE;N7+/W2;?0BSPR1W& I^L8X'K
M6&";([4C QY'>H_V\*]L#_\OVL-M!T^+U2@"%<%802)56P4HP<D,%"S01DF7
M%0O;<<8Y#T!E..!: [C%\0%J)QZ;MBFFY'.:"C LRAEF9MB:D504<NBH,).8
M@!I9!J(:%BI5UYA=--)UH3QY8+%4FP;:)-ZG2L^:VOH39H(F/3P/D2X4_4HS
M(AV6>7S$0V!=FQY4\E63<?=R8MZ-V01,^\0W(2\");'XZXK[![*BNE$JZWB]
MC6$RVB"]:R,J/RGXF]ZU0^9TK2S)&?,LN>+L\BAX6Z>IJI*,0S%.#NS"=Z+<
M..>%BA"O;WP=ZLO+W%DP?&B+NAW!:I(XU_&$6S.5@\7*)@7F^FUIK9&XOD+^
M>W!#M'$Q.$?Z.",;E'[9?DM*#?W.^#(.L)!:CBOT6#>J'?EI;U0PT F*"Q12
MS*2K*'VUK(J:+')BDEAX(: CVAW) ;PXSQC*J^1*/AK*323&T^=@7TFAW'H7
M.W;Q^>+C9C'7^!3Q^=IP=K/K_/'^)25Y@PF@K<I!-JBJ,Q>(_"AZ&!?624ZA
MR;;9WU]'9I9LYXO%V]F9Q] ;36.$K@9 %[L/420Z[J[U7G3LQ<LFH% 'EX0-
M^5<-]Y,CUCUBRT2<.6)<\&"/&:9%1Y\1QJQ<GZROMYO[N]W[V!6ZV7OYY(GK
M#-L(.KU@UOGU9.W\6K+Z+4S6CK.T[. (Z2,"HKBR^EQ>VJ-EBS-TBL#S]>YT
M[,[^8E6P1]GNW2E)(@X8CA'5>?BEK LVH3"P(CG!5)GJVG8>(L-2:P ?!?;
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M%W1S&#=8;QYC9T,\#AT.6J YTYG)Z6E_D^O>"@;CJ"/*$&K-'UN8&0<QYG<
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MEFQG=#GXL4[?X>7=,>2L@UFEG5%ZZHWIPLWD!L+D+I4YWD?2$[6.912N4N1
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MP>+P8WO<NHLS%C&OD#^%"#L'K$.'66-$M!A%TFLLT;[HR,<&3$I>5(F<))G
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MN0*373YC9:%76NY8G?MMND3% AORO"J8TS7@/L=\ 6)\Y6PCEQ!'*U3LC(M
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M1SI!;[SH),4)1FUGDR4"9ILQ2[BX&(_W10[7"D=+"EAU5;BRITO[(#7#9^0
M%V@RA8H_65P8@<@P&QQU$!G'E6Y[X#%9"Z@3+6'@<6LN7?GP8!;228YE3W'P
M!PY#H_@Y, DH$>R>>] .!)$Z)F; J"F/G6)E/ !K46%YX>*%M2QF*!_26<R0
ME+!BB-P969_'\>M#[0Q:2N_X\T'GR]G76;BPZ:9</,*7ZNNBWYUUEK52EAA@
MH>UH6 #J/WV)@0WI?+G^_FUA%ND?'TY&LPW!G>:7=N&LVVY^+30O^NWN$:'V
M YUZL>$,SX N;$$>L7!6.H8<45CQDRK_0#NPJ\"<$#P7TD7R!&0* [^>9V,
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ME' 7Q QY7FRF$O/5:L<>B4*]<%)0CXG[: AZ3[DM$U-H2;F'YL]DB13C<GC
MH&L*Z$_\%XU?),]/@=J>2\:N%1[70;9S ]S5(<:>K#UD%$5_-H\)-@);#*H4
MM-L4' 'P%M+;#11@+M_';0G(KO-6TA4(KW;PI<O!?&A%05^8+!P,8C:P::&P
MSP9.[I88, =<>#_-<^"EA+L>LC<Z_'A1W%J>,65*4_*M@CU=>G0G:\?VDV,X
M4=^-%+Q/8^T8A'KF!NVEIFR&E]?92NFB5VN-X^<S7Q&0LQ3JCP:RB_=U(*]2
M,N8.'P=C<L\BL0B=8I >W".%1RRE6(/>M1GN7VU4?HY%RW?Q?I!(;<!<1JZ
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M!3OXSL'(RH_:_>!O3[W3<%O]I-73#PPG15]*'NKRLJ+6JXK:*&<!YK@/@D[
M((G@;3X ]A3*13QE) G>2RY7) _^$N[:FE_]R^7QC>2Q5E5J6BZ+NV(CWUL6
MU_E>8RZ+;R2+FE+1P#3BAUIV61PW^-CVDX_4K_.Y[=7?ULX#Y6RN+N]-H(Q?
MI8=P=.)ZU,8OSD?!*:&@F)S"@(>!K&">:P<R,$W4P>#5A/"7.5XJT(Y"XE]^
MJNM:[=@C#AU#M,L>F0E=0#MW"*$Y?H[^!T?#$<(6,/5F'Y[/H^6_A">01\NY
M1W J[SFI@X>^XR[!+GCH>;3\W@+RUY?'<L-0*G@:,!?&G3"2[RV,>;C\GL;1
MJ"I55<N%,;>,./B9<.^8(-<0/_Z&05LNE>\BE8D]%KLLEWD2:U>36,;>)[$P
MGT3'S+'&N*>#.A8FLGSJ,_D<9:MT5:N0F['#!X%'VG\&W)_*#-8LJ]6QJ9.G
MJO)4U>Y[X7FJ*K?[F*I2@=54-5],SAWR/%7U[O)H5#6EBAO6<V'<"2/YWL*8
MIZK><]>CIBIZGC?.+6.>JMHAJ<Q352M353A.%'IWOIQ]S4Y%/<5V.BJ'5R!P
MZ;XN^MU99QDGMDAB@(6VHV%!N ]/7V+&@'2^7'__MC"+](\/)Z.9ENLTO[0+
M9]UV\VNA>=%O=X\(M1_HU#N.,A,HOPY+ 7-,1BS*-4#$'Q]D^4F5?[+46E1T
M4%K$P*_GV1A -+YX_OV;UA5W[I[%0(JX6>KO"1>MR<H9HH:3R62J'Y-U.AF<
M7OIL3!I%50N!(*D?%]RACLFI37IQ?LZ3";OVXX@/N(_IM,'I&P"^2N;>8)1#
MZU,X4#0</XTG>5+B?Y$YOLLH.YS.+U<W2^>'NF=[9E]3BRL^0__";/ZV 3VA
M9"38\/,!>_R_:K6BU2K%D3^>D:K@,;, PPMJ^D<L%)MCO%/;->_('U18'CD#
M1>**B4(N';-(FIC^9Y;4)=TP^6^MS/:?E.CI-M+WFQU&7O!-<^9>G[E77.FP
M([S=<@&KI$-O&? F.%? P[@=^ISZE%QPH.XAGA:VD%T?N#_BCEQENG1L[C#R
M^UGWBEBN&:!M_+2]<_,O68!Y5L'G0^S.$%M21ME7.8!/U[O\<MWL?^^V>^NX
M9UL(TI8HQ[?0OYU > %X'KB@C'(H&%@+$;FFT=IQCYF!X#Z'[MN/YH@Z(-I-
M4RXM:XVRH<A*77F7@,"N1M0C5F!/B4D##\0<A-R#CB>ND,,,&/$ QU  A@C\
M07@QHO8P7F^&8(:)J,*("18XT$9V!YIMY J8BE7\D9SV4IN4-D/IL.Y5 = 3
M<[;$$E30&"9^/R#WDKL!-'?RG(5X?"4.%^ _. 7ESXZ2X4#X_S<Z)=&=$4M,
M&T2U@%F 6%\T]>7Z?'+E]YQ;#X+@K^2/9O>\1\Z:UZV;;@>\LNO6>OM*-'T^
M#:WVGO-X]@*[G>>PM9!=WA&660)L!(U,8BSF!<.?<_ KB:FD$!^FSG=A.OO-
MZ%G$2'+]TAS:GLC!4OC?5S)0VV\E2WAP>@:M3DK8X;8$+O0!"J&(P3 P?\^U
MN247DU2%X-]/2^1RGS%9\DJQ3R31V2^2E@VVN^=SQV'^FGLN]DP!Y);NAP&[
MU)BM Z[\V=@NV(L,KD#@$Y_K_HV;*VZ:SQD^9_@]8_B.8!['2!5*!*->()B0
MV>36B+-ASNXK-Q0\RW^K6R-#1"F%:&&[D=CIG,$C\Z7$F_">B9=3YB6[ -XR
MJQ>M,5\U>_W"?,D\<TE_JTOU,1#P2S3SD3^V3_\?4$L! A0#%     @ S&JA
M6(K$3^!630  S-T!  T              ( !     &5X7S8V-3$W-2YH=&U0
M2P$"% ,4    " #,:J%8O]RC<V0#  !M#0  $0              @ &!30
M<WEB="TR,#(T,#0R-2YX<V102P$"% ,4    " #,:J%86Y+=Y]@$  #D+
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C,C0P-3 Q7SAK+FAT;5!+!08     !@ & (0!  #L?      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>sybt20240501_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sybt-20240425.xsd" xlink:type="simple"/>
    <context id="d20248K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000835324</identifier>
        </entity>
        <period>
            <startDate>2024-04-25</startDate>
            <endDate>2024-04-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20248K" id="ixv-607">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20248K" id="ixv-608">0000835324</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20248K" id="ixv-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20248K" id="ixv-618">2024-04-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20248K" id="ixv-27">STOCK YARDS BANCORP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20248K" id="ixv-37">KY</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20248K" id="ixv-43">001-13661</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20248K" id="ixv-48">61-1137529</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20248K" id="ixv-55">1040 East Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20248K" id="ixv-57">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20248K" id="ixv-59">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20248K" id="ixv-61">40206</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20248K" id="ixv-67">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20248K" id="ixv-69">582-2571</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20248K" id="ixv-619">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20248K" id="ixv-620">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20248K" id="ixv-621">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20248K" id="ixv-622">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20248K" id="ixv-623">Common stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20248K" id="ixv-624">SYBT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20248K" id="ixv-625">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20248K" id="ixv-626">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
